Louisiana Wholesale Drug Co. v. Bayer AG

Petition for certiorari denied on March 7, 2011

Docket No.	Op. Below	Argument	Opinion	Vote	Author	Term
10-762	2d Cir.	N/A	N/A	N/A	N/A	OT 2010

Issue: Whether, absent patent fraud or sham litigation, a brand drug maker's substantial payment to a competing generic drug maker to forgo judicial testing of the patent and restrict entry is per se lawful under the Sherman Act.

Briefs and Documents

Opinion below (2d Cir.)
Petition for certiorari
Brief in opposition of Barr Laboratories et al.
Brief in opposition of Bayer AG et al.
Petitioners' reply
Amicus brief of the American Antitrust Institute
Amicus brief of California et al.
Amicus brief of 86 Professors
Amicus brief of the Consumer Federation of America et al.
Amicus brief of AARP
Amicus brief of the Public Patent Foundation
Amicus brief of the National Association of Chain Drug Stores, Inc.

Breaking News

Louisiana Wholesale Drug Co. v. Bayer AG

Briefs and Documents

Certiorari-stage documents

Supreme Court to hear Trump’s bid for criminal immunity

Ghost guns, six-person juries, and discretionary visa decisions

Justices divided over Jan. 6 participant’s call to throw out obstruction charge

Justices limit securities liability for omission of material facts